Atlas Trials

A Phase III Trial of Z-338 in Paediatric Patients With Functional Dyspepsia

Clinical trial NCT04526119 · COMPLETED

Trial details

NCT number
NCT04526119
Sponsor
Zeria Pharmaceutical
Status
COMPLETED
Phase
Phase 3
Study type
INTERVENTIONAL
Functional Dyspepsia
Start date
2021-02-22
Primary completion
2026-03-02
Enrollment
55

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.